CreditReports.dk
HomeScreen companies

BILLEV PHARMA ApS Financials, key figures and credit report

CVR number: 81814813 Established 1977 Industry: 74 Other professional, scientific and technical activities
Company contact details
Slotsmarken 10, 2970 Hørsholm billev@billevpharma.dk tel: 47522600
Gross profit 38 801.3 kDKK FY 2025 +24.4% vs 2024
EBIT 13 077.1 kDKK FY 2025 +65% vs 2024
Net debt -8 205.0 kDKK FY 2025 -80.9% vs 2024
Quick ratio 2.9 FY 2025 +0.7 vs 2024

Company information

Official name
BILLEV PHARMA ApS
Personnel
29 persons
Established
1977
Company form
Private limited company
Industry

Data sources and methodology

The information about BILLEV PHARMA ApS combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2025.

Open the 2025 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About BILLEV PHARMA ApS

BILLEV PHARMA ApS (CVR number: 8181481-3) is a company from HØRSHOLM. The company recorded a gross profit of 38.8 mDKK in 2025. The operating profit was 13.1 mDKK, while net earnings were 10.2 mDKK. The profitability of the company measured by Return on Assets (ROA) was 93.6 %, which can be considered excellent and Return on Equity (ROE) was 120.1 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 66.8 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. BILLEV PHARMA ApS's liquidity measured by quick ratio was 2.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2021
2022
2023
2024
2025
Volume
Net sales
Gross profit30 170.8029 072.5324 763.2331 189.0638 801.27
EBIT7 761.346 393.934 356.677 923.1813 077.15
Net earnings6 013.164 943.063 378.546 143.8510 205.64
Shareholders equity total6 333.165 263.063 698.546 463.8510 525.64
Balance sheet total (assets)10 361.538 946.506 910.9512 279.7515 764.74
Net debt-4 888.86-4 033.34-2 362.28-4 536.73-8 204.98
Profitability
EBIT-%
ROA78.9 %66.4 %55.3 %82.9 %93.6 %
ROE98.6 %85.3 %75.4 %120.9 %120.1 %
ROI125.4 %108.6 %96.1 %143.3 %146.9 %
Economic value added (EVA)5 744.924 659.433 121.045 969.019 822.26
Solvency
Equity ratio61.1 %58.8 %53.5 %52.6 %66.8 %
Gearing12.4 %
Relative net indebtedness %
Liquidity
Quick ratio4.24.02.72.22.9
Current ratio4.24.02.72.22.9
Cash and cash equivalents4 888.864 033.342 362.285 336.738 204.98
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2025
93.6%
Rating 100/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2025
66.8%
Rating 51/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of BILLEV PHARMA ApS before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Roles

Companies in the same industry

Page generated